Vitargent Biotechnology's Series A Round

Vitargent Biotechnology raised a round of funding on January 23, 2015. Investors include WI Harper Group.

Vitargent Biotechnology develops bio-testing technologies that include transgenic medaka and zebrafish fish embryo toxicity testing technologies.…

Articles about Vitargent Biotechnology's Series A Round: